Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Immuneering Corporation on June 12, 2024. The filing details the voting results for director elections and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
No material financial changes are reported in this document. The primary event is the successful election of two Class III directors and the ratification of the accounting firm.
Outlook, Risks, and Management Commentary
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. It strictly documents the outcomes of the shareholder vote.
Key Facts for Investors
- Meeting Attendance: 20,606,257 shares were present, representing approximately 69.5% of outstanding Class A common stock.
- Director Election: Robert J. Carpenter and Benjamin J. Zeskind were elected as Class III directors to serve until the 2027 Annual Meeting.
- Voting Results:
- Robert J. Carpenter: 11,180,033 votes FOR; 3,731,579 votes WITHHELD.
- Benjamin J. Zeskind: 14,395,855 votes FOR; 515,757 votes WITHHELD.
- Auditor Ratification: The appointment of RSM US LLP as the independent registered public accounting firm for the year ending December 31, 2024, was approved with 20,337,444 votes FOR.